NEW YORK, NY / ACCESS Newswire / March 12, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...
NEW YORK CITY, NY / ACCESS Newswire / March 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
Bank of New York Mellon Corp grew its position in GSK plc (NYSE:GSK – Free Report) by 2.2% during the fourth quarter, ...
In this article, we are going to take a look at where GSK plc (NYSE:GSK ... research and development of new medicines, and design, manufacture, and sell diagnostic instruments and tests.
GSK plc (NYSE:GSK) is continuing to strengthen its pipeline, with 11 positive phase III trials reported in 2024 and five new product approvals anticipated in 2025. These include Blenrep for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results